Table 1:
Demographics and clinical characteristics of healthy and GDM placentas used.
| Group | Race | GCT | Medication | |||
|---|---|---|---|---|---|---|
| MALE | ||||||
| Health | ||||||
| #1 | 19 | Black | 26.4 | 89 | - | - |
| #2 | 25 | Black | 33.2 | 90 | - | - |
| #3 | 23 | Black | 26.9 | 130 | - | - |
| #4 | 28 | White | 28.3 | 97 | - | - |
| #5 | 25 | White | 29.5 | 91 | - | - |
| Average | 24 | 28.86 | 99.4 | |||
| GDM | ||||||
| #6 | 32 | White | 32.6 | 153 | 27 | NPH |
| #7 | 30 | White | 38.1 | 246 | 24 | Detemir |
| #8 | 31 | Asian | 25.7 | 211 | 25 | NPH |
| #9 | 40 | Black | 28.4 | 234 | 25 | NPH |
| Average | 33.25 | 31.2 | 211 | 25.25 | ||
| Male Healthy vs. GDM | p=0.0159(*) | p=0.7302(ns) | p= 0.0159(*) | |||
| FEMALE | ||||||
| Healthy | ||||||
| #10 | 23 | Black | 24.9 | 46 | - | - |
| #11 | 25 | Black | 20.5 | 116 | - | - |
| #12 | 27 | Black | 28.8 | 83 | - | - |
| #13 | 29 | White | 24.1 | 94 | - | - |
| #14 | 29 | White | 26.9 | 114 | - | - |
| Average | 26.6 | 25.04 | 90.6 | |||
| GDM | ||||||
| #15 | 30 | White | 30.3 | 189 | 26 | NPH |
| #16 | 39 | White | 33.8 | 173 | 15 | NPH |
| #17 | 34 | White | 29.1 | 187 | 29 | Metformin |
| #18 | 35 | Asian | 25.4 | 190 | 26 | NPH |
| #19 | 38 | Black | 45.3 | 170 | 27 | Glargine |
| Average | 34.5 | 29.65 | 184.75 | 24 | ||
| Female Healthy vs. GDM | 0.0079(**) | p=0.0317(*) | p=0.0079(**) | |||
GCT = 1-hour glucose challenge test; GA = gestational age; NPH: neutral protamine Hagedorn Insulin. Significance was calculated between healthy and GDM values with a Mann-Whitney test.